ABSTRACT-The effect of vesnarinone (OPC-8212), an orally active positive inotropic agent was studied in tracheal muscle isolated from guinea pigs, and the mechanism of its action was analyzed. Vesnarinone (10-6 -10-4 M) caused a concentration-dependent relaxation of tracheal muscle pre-contracted by 10-4 M histamine. The potency of the relaxing effect of vesnarinone was greater than that of theophylline; the pD2 values for vesnarinone and theophylline were 4.9 and 4.5, respectively. Vesnarinone reduced the high-K+ induced contracture of depolarized tracheal muscle non-competitively (pD'2=3.7). Vesnarinone at the low concentration of 3 x 10-6 M shifted the concentration-response curve for isoproterenol in a parallel fashion to the left. Vesnarinone additively acted on the relaxing effect of isobutyl methyl xanthine. Propranolol (10-5 M) and reserpine pre-treatment (5 mg/kg, i.p., 24 hr) had no effect on the relaxing effect of vesnari none. These results suggested that vesnarinone elevated the intracellular cyclic AMP level via phosphodiesterase inhibition, resulting in the tracheal muscle relaxation.
Vesnarinone (OPC-8212) is an orally active positive inotropic drug that was synthesized by Tominaga et al.
(1). Yamashita et al. (2) reported that it had a useful pro file in the treatment of heart failure because it caused a se lective positive inotropic effect with no obvious positive chronotropic and vascular effects. We previously studied the mechanism of the positive inotropic effect of vesnari none in guinea pig papillary muscle (3) . We found that ves narinone strengthened the slow membrane action poten tial, whereas the muscarinic agonist carbachol inhibited the positive inotropic effect of vesnarinone. Taira and colleagues (4) (5) (6) reported that vesnarinone inhibited the cyclic AMP phosphodiesterase and elevated the cyclic AMP level, thereby producing its positive inotropic effect. Rapundalo et al. (7) also showed that vesnarinone inhibited the low-Km phosphodiesterase. These results sug gest the involvement of cyclic AMP in the positive inotropic effect of vesnarinone. As for the lack of a posi tive chronotropic effect, lijima and Taira (8) showed that vesnarinone decreased the outward potassium current, and Yanagisawa et al. (9) suggested that the absence of the chronotropic effect was related to the effect on the potassium current.
In general, c-AMP-phosphodiesterase inhibitors relax tracheal smooth muscle (10) . We first observed the relax ing effect of vesnarinone on the tracheal muscle strips (11) . However, there have been no other reports on the effect of vesnarinone in tracheal muscle. The present ex periments were carried out to extend our previous study on the relaxing effect of vesnarinone in the airway smooth muscle, and to examine whether the mechanism of its ac tion was dependent upon the phospodiesterase inhibition in the same manner as methylxanthines.
MATERIALS AND METHODS

Tracheal muscle preparations
Guinea pigs of either sex, weighing from 300 to 450 g, were used. The tracheae were excised from the animals killed by a sharp blow on the skull. The muscle strips were prepared from the excised trachea by cutting it spirally with a sharp scalpel (12, 13) into strips of 20 mm length with a width of 2 to 3 mm. The muscle strip was mounted vertically and suspended at a resting tension of 1.0 g in a chamber containing a modified Tyrode solution of 50 ml.
Bathing solution
Two kinds of bathing solution were prepared: The com position of the Tyrode solution was as follows: 137 mM NaCl, 12 mM NaHCO3, 0.42 mM NaH2PO4, 1.8 mM CaC12, 2.7 mM KCI, 0.52 MM MgC12 and 5.6 mM glucose (pH = 7.4 at 37C). In the experiments to examine the ex tracellular calcium concentration dependence of high-K+ induced contractions, a K+-rich, Ca2+-free Tyrode solu tion was used. The total K+ concentration was raised to 40 mM by replacing equivalent amounts of NaCI with that of KCI, thereby bringing the muscle strips to a partial ly depolarized state. The bathing solution was constantly gassed with a mixture of 95% O2 and 5% CO2 and kept at a temperature of 371C.
Measurement and recording of tension The muscle tension was measured isometrically by means of a strain-gauge type transducer (SB-1T-H, Nihon Kohden, Tokyo) and an amplifier (RP-5, Nihon Kohden), and recorded on the graph paper of the recording device (VP-6521, Matsushita Communication Industrial, Yokohama). The resting force of the preparation was kept constant at 1.0 g. All test preparations were allowed to equilibrate for at least 40 min in a normal Tyrode solu tion before drug application. 
RESULTS
Relaxing effect of vesnarinone on histamine-induced con tracture Vesnarinone produced a relaxation of the tracheal mus cle that was pre-contracted with 10-4 M histamine in Tyrode solution. Vesnarinone (in sulfolane: final concentra tion kept constant at 0.3 %) caused a relaxation concentra tion-dependently in a range from 10-6 to 10-'M. Sulfo lane, the solvent of vesnarinone, had a weak relaxing potency at 0.307o (final concentration); At a final concen tration of 0.3%, it relaxed the tracheal muscle by 16.8%
( Fig. 1) . Accordingly, all experiments to observe the relax ing effect of vesnarinone and theophylline for histamine contraction were carried out in the presence of 0.3% sulfo lane. Each concentration of compound with 0.3% sulfo lane was administered in a bolus single shot and then washed out 3 times by drug-free Tyrode solution. Hista mine (10-4 M) caused a reversible contraction of almost the same extent. Therefore, the concentration-relaxation relationship for each compound was plotted after sub tracting the relaxing effect of 0.307o sulfolane alone. Since the maximum relaxation occurred with 3 x 10-'M theo phylline plus 0.3 % sulfolane, this response was plotted as 100% relaxation in Fig. 2 . The relaxing potencies of theophylline and vesnarinone expressed by the pD2 values were 4.47 ± 0.02 (n = 6) and 4.94 ± 0.03 (n = 4), respective ly. The pD2 value of vesnarinone was significantly larger than that of theophylline (P<0.01).
Influence of l propranolol and reserpinization on the relaxant action of vesnarinone
In our previous study (3), we reported that the positive inotropic effect of vesnarinone developed with or without 131-receptor blocking. Experiments were carried out to ex amine the role of f32-receptors in the relaxing effect of ves narinone on histamine-induced contractures of guinea pig tracheal muscle. The concentration-response curve for vesnarinone was not affected by the presence of 10-5 M l-propranolol (Fig. 3) . Also, reserpine pre-treatment (5 mg/kg, i.p., 24 hr) had no effect on the relaxing effect of vesnarinone (data not shown). Relaxing effect of vesnarinone on carbachol-induced con traction The relaxing effect of vesnarinone on the contracture of tracheal muscle strip induced by the muscarinic agonist carbachol (10-'M) was examined in same manner as in Fig. 1 . Vesnarinone (in sulfolane: final concentration kept constant at 1076) caused a concentration-dependent relaxation in a range from 10-5 to 3 x 10-'M. Sulfolane (1070) alone relaxed the tracheal muscle by 21.807o. Accord ingly, all experiments to observe the relaxing effect of papaverine, vesnarinone and theophylline for carbachol contraction were carried out in a condition of constant presence of 1070 sulfolane. The results are shown in Fig. 4 . The concentration-relaxation curve for each compound was plotted after subtracting the relaxing effect of 1010 sul folane alone. The relaxing response to 10-4 M papaverine was taken as 100% relaxation. Because of the restriction of water solubility of vesnarinone or theophylline, we could not examine the relaxing effect in the higher dose range of these compounds. The pD2 value of vesnarinone and theophylline was 3.63-:L0.04 (n=4) and 3.22±0.04 (n=4), respectively. The pD2 value of vesnarinone was sig nificantly larger than that of theophylline (P<0.01).
The relaxing effect of vesnarinone on high-K+-induced contracture of tracheal muscle Figure 5 shows the influence of vesnarinone on the con tractile effect of Ca 21 in partially depolarized tracheal smooth muscle. The tracheal muscle strips were first incu bated in normal Tyrode solution, washed 3 times with the Caa+-free Tyrode solution and then incubated in the Ca" -free and K+-rich (40 mM) solution for an hr. In the control ex periments, we added CaC12 cumulatively into the bathing solution in the absence of drugs. The second control ex periments were carried out in the presence of either 0.03, 0.09 or 0.307o sulfolane, since sulfolane itself relaxed the tracheal muscle. Then the muscle strip was washed again with the Ca2+-free Tyrode solution and treated for 10 min with either 10-5, 3 x 10-5 or 10-4 M of vesnarinone in 0.03, 0.09 or 0.3010 sulfolane (Fig. 5: A, B, C) . Subse quently, CaC12 was added to the bathing solution by the same procedure as used in the control experiments. The Ca 21 concentration-response curve with 10-5 M vesnari none was shifted to the right in a parallel fashion (Fig.  5A) . The pA2 value of competitive antagonism of vesnari none with regards to the high-K+-induced contraction (in presence of sulfolane) was 5.22±0.05 (n=5). At the higher concentrations of 3 x 10-5 M and 10-4 M vesnari none, a downward shift of the curve was observed (Fig. 5 : B and C). Vesnarinone non-competively antagonized the high-K+-induced contraction (in the presence of sulfo lane) with a pD'2 value of 3.71±0.05 (n=5). Reserpine pre-treatment (5 mg/kg, i.p., 24 hr) did not affect pD'2 value for the relaxing effect of vesnarinone (3.73 ±0.04, n=5). 
Potentiation of the relaxing effect of isoproterenol by ves narinone
From the reported evidence (3, 5) that vesnarinone potentiated the positive inotropic effect of isoproterenol in guinea pig papillary muscle, similar experiments were performed using guinea pig tracheal muscle. Six tracheal muscle preparations were divided into two groups. One group was treated with 3 x 10-6 M vesnarinone in 0.009% sulfolane, and the other group was treated with sulfolane alone in an equivalent dose. The preparations of both groups were equilibrated for 10 min. The following experi ments were carried out in the presence of 0.009% sulfo lane. During the time of incubation, vesnarinone produced a slight relaxation of the tracheal muscle (9.8 ± 1.1 % of maximum contraction produced by hista mine). Next, all the tracheal muscle strips were contracted by adding 10-4 M histamine. Then isoproterenol was cu mulatively added into the bathing solution in concentra tions ranging from 10-10 to 3 x 10-' M. After the maxi mum response of relaxation, each group of muscle strips was washed with normal Tyrode solution at least 3 times. Subsequently, the experimental protocols were exchanged between the two groups. The maximum extent of relaxa tion by 3 x 10-' M isoproterenol was taken as 100010 re laxation. Thus the concentration-response curves for iso proterenol were depicted as shown in Fig. 6 . The pD2 values for isoproterenol determined from the curves in the absence and presence of vesnarinone were 7.91 ±0.03 and 8.48±0.06 (n=6), respectively. Vesnarinone sig nificantly (P<0.01) shifted the concentration-response curve for isoproterenol to the left in a parallel fashion, but the maximum relaxing effect of isoproterenol was not significantly affected by vesnarinone.
Influence of vesnarinone on the relaxing effect of IBMX The potentiation of the relaxing effect of isoproterenol on tracheal muscle by vesnarinone lead to the next experi ment to assess the phosphodiesterase inhibition. If the mechanism by which vesnarinone relaxed tracheal muscle originated from phosphodiesterase inhibition, there must exist an additive correlation between this drug and IBMX, a well-established phosphodiesterase inhibitor (14, 15) . Figure 7A shows the control concentration-re laxation curves of IBMX and the theoretical curves (dotted lines) calculated from the assumption that IBMX and vesnarinone additively acted on the same mechanism. Figure 7B shows the concentration-relaxation curves of IBMX on guinea pig tracheal muscle in the presence of vesnarinone. Symbols and bars represent the mean±S.E. Numbers of experiments were 6. Figure 7 shows the influence of vesnarinone on the con centration-relaxation curves for IBMX in tracheal muscle contracted by 10-4 M histamine. Tracheal muscle prepara tions were divided into 4 groups, and vesnarinone at a concentration of 0 (0.03% sulfolane alone), 3 pM, 6 pM and 10 pM were added into the bathing solution in a state of histamine-induced contracture. The final concentra tion of sulfolane was kept at 0.03%. Vesnarinone relaxed the tracheal muscle by 9, 32, 45% of the maximum relaxa tion produced by IBMX. The extent of the maximum relaxation by IBMX was almost the same as the maximum response by papaverine or vesnarinone. IBMX was added cumulatively to the tracheal muscle preparations of the respective group, from which four concentration-relaxa tion curves were obtained. Figure 7A shows the theoreti cal curves calculated from the assumption that IBMX and vesnarinone additively acted on the same mechanism. Comparing the pD2 values (4.94 and 5.92) obtained from the data in Figs. 2 and 7 , vesnarinone at the concentration of 3, 6 and 10 pM will be equipotent to IBMX concentra tions of 0.3, 0.6 and 1 pM, since the potency of vesnari none was 1/10 of that of IBMX. The expected curves could be drawn, like those in Fig. 7A , that show the con centration-relaxation curve of IBMX in the presence of any drug having the same mechanism of action. Figure 7B shows the concentration-relaxation curves of IBMX on guinea pig tracheal muscle in the presence of vesnarinone. Vesnarinone shifted the concentration-response curve for IBMX upwardly, rather than in a parallel fashion. The maximum relaxing effect of IBMX was not significantly affected by vesnarinone. 
DISCUSSION
The present experiments clearly showed that vesnari none relaxed the guinea pig tracheal muscle dose-depend ently. The potency of this drug for the relaxation was 2 to 3 times stronger than that of theophylline either for hista mine or carbachol-induced contracture. For carbachol induced contracture, the relaxing effect of vesnarinone was, however, less potent than the histamine-induced one as observed in the case of theophylline, nitroglycerin or isoproterenol for acetylcholine-induced contracture (16) . Propranolol or reserpine pre-treatment had no effect on the relaxing effect of vesnarinone.
The following observations have been made about the positive inotropic effect of vesnarinone on the heart mus cle: 1) The positive inotropic effect was decreased by car bachol (3, 5, 6) . This suggested the involvement of cyclic AMP in the positive inotropic effect, since carbachol was generally accepted as a depressant for cyclic AMP-mediat ed intervention (17) (18) (19) . 2) Vesnarinone potentiated the positive inotropic effects of isoproterenol and histamine, adenylate cyclase stimulators (3, 5), but did not affect the dose-response curves of cardiac glycoside (3). 3) Vesnari none increased the force of rested-state contraction like 3 agonists, phosphodiesterase inhibitors and dibutylyl cyclic AMP (3, (20) (21) (22) . 4) The slow action potentials elicited from partially depolarized guinea pig papillary muscle were increased as like ~-agonists and phospho diesterase inhibitors (3, 22 24) . These results suggest that vesnarinone increases the cyclic AMP levels in the myocardium and produces the positive inotropic effect.
We also observed in another study that vesnarinone in creased the cyclic AMP level significantly in guinea pig Langendorff heart (25) . In analogy, the involvement of cyclic AMP will be assumed in guinea pig tracheal muscle relaxation. It is generally accepted that an increased cyclic AMP in tracheal smooth muscle is closely associated with the relaxation as suggested by Murad and Kimura (26) and Newmann et al. (10) .
There are two ways to increase the intracellular cyclic AMP: One is the stimulation of adenylate cyclase, and the other is to inhibit the activity of phosphodiesterase, a cyclic nucleotide inactivating enzyme. The present study showed that vesnarinone and IBMX interacted additively to relax tracheal muscle at a potency ratio of 1:10. This supports the view that vesnarinone acted on the same mechanisms, like the action of IBMX, while the existence of a potentiative relationship between isoproterenol and vesnarinone on tracheal muscle, just like the case of its positive inotropic effect (3, 5) , favors the view that in tracellular cyclic AMP was increased by phospho diesterase inhibition, not by adenylate cyclase stimula tion. Taira et al. (4) showed that vesnarinone inhibits cyclic AMP phosphodiesterase.
Rapundalo et al. (7) also reported that vesnarinone is a selective inhibitor of the low-Km, c-GMP-inhibited phosphodiesterase (CGI PDE).
The present study showed that vesnarinone is not only an inotropic drug with a moderately high potency (3) but also a potent relaxant of airway smooth muscle. The relax ing potency of vesnarinone was 3 times more potent than that of theophylline. The clinical application of vesnari none for the treatment of heart failure is restricted from the incidence of agranulocytosis. However, Busch et al. (27) reported that the toxic effect of vesnarinone on bone marrow progenitor cells was dose-dependent and not ex hibited at very low drug concentration, with a threshold at the lower end of the therapeutic range. In this study, we found that the pD2 value of vesnarinone on tracheal muscle relaxation (pD2=4.94) was larger than that on the positive inotropic effect (pD2=4.27) in guinea pig papil lary muscle (3). Vesnarinone will act more selectively on tracheal smooth muscle than on cardiac muscle. These results suggest the possibility of another clinical applica tion of vesnarinone for the treatment of obstructive at tack of the respiratory way.
